SMG9
Basic information
Region (hg38): 19:43727983-43754962
Previous symbols: [ "C19orf61" ]
Links
Phenotypes
GenCC
Source: 
- heart and brain malformation syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source: 
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References | 
|---|---|---|---|---|---|
| Heart and brain malformation syndrome; Neurodevelopmental disorder with intention tremor, pyramidal signs, dyspraxia, and ocular anomalies | AR | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular; Craniofacial; Neurologic; Ophthalmologic | 27018474; 35087184 | 
ClinVar
This is a list of variants' phenotypes submitted to 
- Inborn_genetic_diseases (68 variants)
- not_provided (32 variants)
- Heart_and_brain_malformation_syndrome (9 variants)
- SMG9-related_disorder (9 variants)
- Neurodevelopmental_disorder_with_intention_tremor,_pyramidal_signs,_dyspraxia,_and_ocular_anomalies (4 variants)
- not_specified (4 variants)
- Abnormal_facial_shape (2 variants)
- Abnormal_cardiovascular_system_morphology (2 variants)
- Global_developmental_delay (2 variants)
- Brainstem_dysplasia (2 variants)
- Autism_spectrum_disorder (1 variants)
- Neurodevelopmental_abnormality (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SMG9 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000019108.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 18 | 21 | ||||
| missense | 72 | 78 | ||||
| nonsense | 5 | |||||
| start loss | 0 | |||||
| frameshift | 6 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 7 | 4 | 74 | 22 | 3 | 
Highest pathogenic variant AF is 0.00007125296
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| SMG9 | protein_coding | protein_coding | ENST00000270066 | 13 | 23842 | 
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p | 
|---|---|---|---|---|---|---|
| 3.46e-13 | 0.278 | 125672 | 0 | 76 | 125748 | 0.000302 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.60 | 240 | 320 | 0.749 | 0.0000189 | 3369 | 
| Missense in Polyphen | 54 | 84.374 | 0.64001 | 835 | ||
| Synonymous | 0.592 | 113 | 121 | 0.932 | 0.00000699 | 1058 | 
| Loss of Function | 1.13 | 23 | 29.7 | 0.775 | 0.00000164 | 304 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.000782 | 0.000656 | 
| Ashkenazi Jewish | 0.000202 | 0.000198 | 
| East Asian | 0.000492 | 0.000489 | 
| Finnish | 0.000187 | 0.000185 | 
| European (Non-Finnish) | 0.000282 | 0.000281 | 
| Middle Eastern | 0.000492 | 0.000489 | 
| South Asian | 0.000263 | 0.000261 | 
| Other | 0.000655 | 0.000652 | 
dbNSFP
Source: 
- Function
- FUNCTION: Involved in nonsense-mediated decay (NMD) of mRNAs containing premature stop codons (PubMed:19417104). Is recruited by release factors to stalled ribosomes together with SMG1 and SMG8 (forming the SMG1C protein kinase complex) and, in the SMG1C complex, is required for the efficient association between SMG1 and SMG8 (PubMed:19417104). Plays a role in brain, heart, and eye development (By similarity). {ECO:0000250|UniProtKB:Q9DB90, ECO:0000269|PubMed:19417104}.;
- Disease
- DISEASE: Heart and brain malformation syndrome (HBMS) [MIM:616920]: An autosomal recessive syndrome characterized by multiple congenital anomalies such as cardiac defects, brain malformations, including cerebellar vermis hypoplasia, hypoplastic corpus callosum and Dandy-Walker malformation, profoundly delayed psychomotor development, microphthalmia, and facial dysmorphism. {ECO:0000269|PubMed:27018474}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Metabolism of RNA;Nonsense-Mediated Decay (NMD);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) (Consensus) 
Intolerance Scores
- loftool
- rvis_EVS
- -0.76
- rvis_percentile_EVS
- 13.45
Haploinsufficiency Scores
- pHI
- 0.129
- hipred
- Y
- hipred_score
- 0.564
- ghis
- 0.583
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium | 
| Primary Immunodeficiency | Medium | Medium | Medium | 
| Cancer | Medium | Medium | Medium | 
Mouse Genome Informatics
- Gene name
- Smg9
- Phenotype
- vision/eye phenotype; limbs/digits/tail phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; renal/urinary system phenotype; immune system phenotype; liver/biliary system phenotype; respiratory system phenotype; embryo phenotype; growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;eye development;brain development;heart development
- Cellular component
- cytosol
- Molecular function
- protein binding;identical protein binding